~~<i id='8E697D6574'><strike id='8E697D6574'><tt id='8E697D6574'><pre id='8E697D6574'></pre></tt></strike></i>~~

Home» explore» fashion

fashion

author：comprehensive 2025-09-28 06:26:40 Page View：9554

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump allegedly attempted to have surveillance video deleted: Special Counsel
Next article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

explore

How to save PrEP access — and even expand it

UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

As the dark side of IVF slowly comes into focus, even more transparency is needed

AselectionofIVFhormonebottlesandsyringesattheScienceMuseuminLondon,England.LeonNeal/GettyImagesIwas1

In Memoriam: Notable people who died in 2023

1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

Vertex cell therapy lets patients with type 1 diabetes stop insulin

CraigF.Walker/TheBostonGlobeVertexPharmaceuticalssaidFridaythat,overayearafterreceivingthecompany’ss